Photo of Judy Blumstock
Executive Director, Corporate Development
Work Phone: 647-260-7863

Biographical Info

Judith provides financial strategy and in-depth portfolio reporting for TIAP and its technologies and companies under management. She also takes an active role in fundraising and investor relations, and leads a variety of special projects.

Prior to joining TIAP (previously MaRS Innovation), Judith was a principal with Genesys Capital Partners, one of the largest Canadian-based venture-capital firms focused on the life sciences industry. She is also a past director of Insception, Millenium Biologix Corp., Plexagen Diagnostics, and Zelos Therapeutics Inc. Previously, Judith was a partner with Royal Bank Capital Partners Life Sciences Fund and, prior to that, director of Bio/pharmaceutical Research at Drug Royalty Corporation.

Judith received her M.B.A. in finance from Columbia Business School and her B.Sc. in Biology from the University of Toronto.

Return to top.
Photo of Dr. Phil Goldbach
Manager, Technology and Venture Development; Manager, Intellectual Property
Work Phone: 647-260-7830

Biographical Info

Phil manages intellectual property (IP) rights across all technologies within TIAP’s (previously MaRS Innovation) portfolio. He advises on various forms of IP protection, assessing patentability and managing patent application filings and prosecution decisions. Phil also manages projects in TIAP’s Life Sciences portfolio. He performs technical and market due diligence on new technologies to support and expand TIAP’s portfolio. In addition, he develops business, technical, and strategic plans and engages with industry partners in order to support new start-up ventures.

Prior to joining TIAP, Phil trained with an intellectual property boutique law firm in downtown Toronto as a member of the firm’s life sciences patent practice group, where he was exposed to a wide array of technologies including biologics, small molecules, medical devices, and information technologies. He has also acted as director of intellectual property for a biotechnology start-up company in Mississauga that specializes in developing antibody-based products for use in animal health and food safety.

Phil holds a PhD in Molecular Genetics from the University of Toronto and a JD from Osgoode Hall Law School.

Return to top.
Photo of Hassan Jaferi
Manager, UTEST
Work Phone: 647-531-4681

Biographical Info

As Manager of UTEST, Hassan works with early-stage startup companies from the University of Toronto and its affiliated hospitals. He helps guide UTEST portfolio companies in the areas of business development, marketing, intellectual property, fundraising and strategy.

Previously, Hassan was a commercialization manager at MaRS Innovation, now Toronto Innovation Acceleration Partners, where he divided his time between projects located in Innovation York and Sunnybrook Health Sciences Centre’s Technology Transfer office, located in the Sunnybrook Research Institute. He conducted due diligence on invention disclosures, aided in patent application preparation and prosecution, executed business development for early-stage technologies and pursued public and private funding to advance early-stage research projects.

Before joining TIAP, Hassan was a commercial development analyst with PARTEQ Innovations, the technology transfer office of Queen’s University, where he managed the commercialization of early-stage technologies and helped managed a start-up company. He has also worked as a patent examiner with the Canadian Intellectual Property Office.

Hassan holds a M.Sc. in space management from the International Space University in Strasbourg, France, and a B.Sc. in computer engineering from the University of Ottawa.

Return to top.
Photo of Ido Kaminsky
Manager, Technology & Venture Development
Work Phone: 647-236-8100

Biographical Info

Prior to joining TIAP, Ido Kaminsky served as the Director of Business Analysis at FutuRx, a biotech incubator jointly established by J&J (JJDC), Takeda Ventures, and Orbimed Israel. There, he conducted scouting, deal flow, scientific and business analysis, and transactional activities. Ido was responsible for expanding FutuRx’s network with research centers and tech-transfer offices, conducting technology evaluation, and licensing IP as part of venture formation processes. In his time with FutuRx he took part in the inception of over 10 biotechnology start-ups.

Ido also spent several years with RM Global Partners, a boutique investment bank and consulting firm in the pharma, biotechnology, and medical-device space. There, he worked on corporate strategy and financing with clients across Israel, the US, and Korea, as well as the inception of a the RMGP Biopharma Investment Fund. Before that, Ido was an Analyst at the Frankel Group, a US-based strategic consulting firm focused on life-science.
Ido holds a M.Sc. in biochemistry from the Weizmann Institute of Science, Israel.
Return to top.
Photo of Dr. John McGraw

Biographical Info

John McGraw joined TIAP as Executive-in-Residence in 2019 to assist our team in identifying and developing opportunities in therapeutics, medical devices & digital health companies.

John received his graduate degrees from UBC specializing in Neuroscience.  During this time, he co-founded a medical device company that successfully developed and commercialized an operating room device. Since then, John has focused on the commercialization of medical devices, health IT, laboratory diagnostics and therapeutics as a consultant or executive leader in public companies.

In addition to his extensive entrepreneurial and consulting experience, John has also provided executive leadership to two public companies. He was VP of Operations for Novadaq Technologies Inc. (NASDAQ: NCVQ), a medical device imaging company which was acquired by Stryker Corporation for US $701M in 2017. He was also SVP Business Development & Strategy for CML HealthCare Inc (TSX:CLC), which was acquired by LifeLabs (owned by OMERS/Borealis) for CA$1.2B in 2013. At LifeLabs he served as the SVP of Sales, Marketing and New Business.

Return to top.
Photo of Dr. Teja Mullapudi
Analyst, Technology & Venture Development
Work Phone: 647-260-8861

Biographical Info

Teja Mullapudi performs market opportunity assessment and scientific due diligence to determine the commercialization potential of projects entering TIAP’s pipeline. He also scouts for promising science and innovation from TIAP’s academic member institutions.

Prior to joining TIAP, Teja conducted market opportunity assessment for a software-as-a-service firm that aimed to enter the healthcare market. During his doctoral training in Prof. Didier Stainier’s lab at the Max Planck for Heart & Lung Research, Teja identified potentially first-in-class anti-diabetic agents to regulate glucose levels through insulin-independent mechanisms. His other past experiences include research on adipose cell biology at Prof. Alexander Pfeifer’s lab at the University of Bonn, and on human immunodeficiency virus (HIV) at the Indian Institute of Technology Madras and the National AIDS Research Institute, India.

Teja holds a Ph.D. from Goethe University, Frankfurt (Dec 2019) in Germany and an M.Tech + B.Tech in Biotechnology from the Indian Institute of Technology Madras in India.

Return to top.
Photo of Parimal Nathwani
President & CEO
Work Phone: 647-260-7873

Biographical Info

Parimal Nathwani has over 15 years of experience in various aspects of the biotechnology industry including corporate finance, business development, transactions, intellectual property management, technology development and operations. He has been actively involved in forming and managing start-ups, preparing and executing on business plans, raising early-stage capital and in- and out-licensing activities.

Before joining MaRS Innovation, now Toronto Innovation Acceleration Partners (TIAP), Parimal was a healthcare analyst with a boutique investment bank, where he conducted equity research on publicly-traded biotechnology companies in Canada and the U.S. He has also led commercialization activities out of BC Women’s and Children’s Hospital as part of his role at the University of British Columbia’s Industry Liaison Office, and was a research scientist at a start-up biotechnology company involved in drug discovery targeting ABC Transporters.

Parimal received his MBA from Simon Fraser University and his M.Sc. from the University of British Columbia.  He currently sits on the boards of TRIUMF Innovations, Zucara Therapeutics, and Vasomune Therapeutics, and is an observer on the board of Encycle Therapeutics.

Return to top.
Photo of Dr. Sohaib Siddiqui

Biographical Info

Sohaib provides medical, scientific and business support to early-stage startups in TIAP’s ecosystem. He works alongside TIAP’s academic and institutional partners to identify promising medical technologies in digital health and medical devices. He works closely with companies to provide subject matter expertise in order to develop impactful technologies that can address the needs of patients, clinicians and healthcare systems.

Prior to joining TIAP, Sohaib worked at Kettlebeck Ventures, a family-office backed healthcare fund where he managed their healthcare strategy. He also trained as a medical doctor and pediatric clinical researcher.  His area of research focused on improving the access and quality of care for pediatric patients in rural and developing countries while improving the operational efficiency of the delivery of healthcare. He concurrently has an academic appointment at Women’s College Hospital as an Innovation Fellow, where he evaluates how new technologies can integrate into the healthcare system.

Sohaib holds a B.ScH from Queen’s University, degrees in Medicine, Surgery & Obstetrics from the Royal College of Surgeons in Ireland, and Executive Education Certification in Digital Health from Harvard Medical School.

Return to top.
Photo of Susanne Staer
Manager, Communications and Corporate Affairs
Work Phone: 647-260-7869

Biographical Info

Susanne is the Corporate Secretary for Toronto Innovation Acceleration Partners (TIAP) and as such is in charge of the integrity of the organization’s governance framework, including compliance with various governing and funding requirements; efficient administration of the Board of Directors and its various governing and advisory committees; and management of the process related to the annual general meetings and accurate record keeping of Board decisions and organizational history.

In addition, Susanne delivers administrative expertise to the executive office, and oversees marketing, external communications, social media and website development. She maintains office efficiency by establishing procedures and standards, and is the point-person for all aspects of the administration of TIAP.

Prior to joining TIAP, Susanne worked closely with two senior partners in a nation-wide law firm, in the areas of mergers and acquisitions, corporate finance and securities, and general corporate matters. Susanne also trained new administrative staff and was instrumental in setting up various intranet functions as they pertained to training and staff administration.

Susanne has an international administrative background through her work in the diplomatic corps under the Ministry of Foreign Affairs of Denmark, through which she was posted to the Royal Danish Embassies in Russia and Ghana.

Return to top.
Photo of Jackie Terry
Program Administrator
Work Phone: 647-260-7870

Biographical Info

Jackie provides administrative support to the boards of several of Toronto Innovation Acceleration Partner’s startup companies in addition to her role as Program Administrator.  She also assists with the daily administration of the LAB150 funding initiative for new drug discovery, and is the liaison between TIAP and its partner, Evotec AG, as well as the main contact for the Technology Transfer Offices and researchers at TIAP’s Member institutions who wish to apply to the LAB150 program.

Prior to joining TIAP, Jackie collaborated on and managed projects in the polymer characterization department of an organization that specialized in contract and service-based research, development and testing. Her specialties were innovative techniques for preparing and analyzing materials using various disciplines of microscopy, particularly scanning electron microscopy, mainly in the fields of materials characterization and failure analysis.

Jackie received her B. Sc. in Chemistry from McMaster University in Hamilton, Ontario.

Return to top.